Maprotiline Hydrochloride (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Maprotiline Hydrochloride drug offered from Mylan Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | maprotiline hydrochloride |
SUBSTANCE NAME: | MAPROTILINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1988-10-03 |
END MARKETING DATE: | 0000-00-00 |
Maprotiline Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Maprotiline Hydrochloride from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 1988-10-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-0060_8ab0b141-aa2a-4329-a77c-da427e79fc39 |
PRODUCT NDC: | 0378-0060 |
APPLICATION NUMBER: | ANDA072285 |
Other MAPROTILINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: